Apetite Supressant

Obesity has become increasing problem in the world. World Health Organization’s has reported that in some parts of Europe about 70 percent of men and woman aged 55-64 are clinically obese or overweight. In United States one person in five is overweight and one in three is obese. This statistic proves prevalence of obesity in [...]

Generic Zimulti

Generic Zimulti
For people with a BMI of 30 or more, everyday life can become an ordeal. Struggling with weight can destroy self esteem, hamper relationships, and even threaten a person’s health. For many, simply trying to diet and exercise is not enough as cravings for food overwhelm even the most concerted attempts at weight loss, [...]

Acomplia clinical trials

About Acomplia (rimonabant) and clinical trials
Clinical trials are undertaken to demonstrate both the effectiveness and the safety of a drug for human consumption. Human clinical trials will only occur after substantial testing in pre clinical studies has demonstrated the likely effectiveness and safety of the medication to be tested. This final clinical trial will help [...]

Generic Acomplia / Rimonabant

Generic Acomplia / Rimonabant
Rimonabant, otherwise known as generic Acomplia was introduced to the market in 2006 as an anti obesity drug. It is recommended for use with people who have a BMI greater than 27, and has been proven in clinical trials to significantly aid weight loss in these patients.
Rimonabant is only effective if combined [...]

Rimonabant Generic Acomplia

Following approval by the European medicine agency (EMES) in June 2006 Rimonabant also known by its brand name Acomplia was made available in Europe by the middle of 2006.This new age drug offers hope for modern ailments by focusing on inhibiting the CB1 receptor, one of the two receptors found in the Endocannabinoid system (or [...]